AwesomeCapital
Search This Blog
Monday, February 25, 2019
Medpace sees 2019 adjusted EPS $2.58-$2.69, consensus $2.92
Sees 2019 revenue $783M-$, consensus $799.27M. It sees 2019 adjusted EBITDA $137M-$145M. The company is providing guidance under ASC 606.
https://thefly.com/landingPageNews.php?id=2869805
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.